Abbott Laboratories (ABT) Cash from Operations (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Cash from Operations data on file, last reported at 1315000000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 7.2% year-over-year to 1315000000.0; the trailing twelve-month figure through Mar 2026 stood at 9464000000.0 (up 5.74% YoY), and the FY2025 full-year result was 9566000000.0, up 11.78% from the prior year.
• Cash from Operations retreated to 1315000000.0 in Q1 2026, from 3315000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 3315000000.0 in Q4 2025 to a low of 1025000000.0 in Q1 2024.
• A 5-year average of 2134176470.59 and a median of 2065000000.0 in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations slumped 50.08% in 2023 and surged 62.93% in 2024, its largest moves.
• Tracing ABT's Cash from Operations over 5 years: stood at 2326000000.0 in 2022, then surged by 30.61% to 3038000000.0 in 2023, then dropped by 5.6% to 2868000000.0 in 2024, then rose by 15.59% to 3315000000.0 in 2025, then tumbled by 60.33% to 1315000000.0 in 2026.
• Business Quant data shows ABT's Cash from Operations at 1315000000.0 in Q1 2026, 3315000000.0 in Q4 2025, and 2787000000.0 in Q3 2025.